Pegoraro, S. (31 January 2017). SC83288 is a clinical development candidate for the treatment of severe malaria. Nature Communications, 8, . doi:10.1038/ncomms14193

"SC83288 is a clinical development candidate for the treatment of severe malaria / Stefano Pegoraro, Maëlle Duffey, Thomas D. Otto, Yulin Wang, Roman Rösemann, Roland Baumgartner, Stefanie K. Fehler, Leonardo Lucantoni, Vicky M. Avery, Alicia Moreno-Sabater, Dominique Mazier, Henri J. Vial, Stefan Strobl, Cecilia P. Sanchez and Michael Lanzer" Nature Communications .

Pegoraro, Stefano. "SC83288 Is a Clinical Development Candidate for the Treatment of Severe Malaria." Nature Communications 8 (31 January 2017).